Bennicas & Associates, Inc. / BMY
Bennicas & Associates, Inc.’s Bristol-Myers Squibb Co Position
Does Bennicas & Associates, Inc. own Bristol-Myers Squibb Co (BMY)? Yes — 25.5K shares worth $2M (+1.06% of its 13F portfolio) as of Q1 2023.
Position Value
$2M
Q1 2023
Shares
25.5K
% of Portfolio
+1.06%
Quarters Held
18
currently held
Position History BMY
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2023 | 25.5K | $2M | +1.06% |
| Q4 2022 | 25.5K | $2M | +1.06% |
| Q3 2022 | 25.9K | $2M | +1.17% |
| Q2 2022 | 26.0K | $2M | +1.17% |
| Q1 2022 | 26.0K | $2M | +0.95% |
| Q4 2021 | 26.1K | $2M | +0.85% |
| Q3 2021 | 26.1K | $2M | +0.87% |
| Q2 2021 | 26.1K | $2M | +0.96% |
| Q1 2021 | 26.2K | $2M | +0.95% |
| Q4 2020 | 26.4K | $2M | +0.96% |
| Q3 2020 | 26.6K | $2M | +1.00% |
| Q2 2020 | 26.8K | $2M | +1.18% |
| Q1 2020 | 26.8K | $1M | +1.32% |
| Q4 2019 | 28.7K | $2M | +1.33% |
| Q3 2019 | 29.0K | $1M | +1.14% |
| Q2 2019 | 29.0K | $1M | +1.10% |
| Q1 2019 | 29.2K | $1M | +1.22% |
| Q4 2018 | 29.2K | $2M | +1.40% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Bennicas & Associates, Inc.’s full portfolio or all institutional holders of BMY.